How The Curtain Finally Closed On Ferring/Blackstone’s Gene Therapy Venture FerGene
Back In Swiss Pharma’s Hands
Having failed to live up to its promising beginnings, FerGene, the gene therapy firm founded with the backing of Ferring and Blackstone to advance the former’s candidate for bladder cancer is back under the Swiss pharma's wing. However, doubts about its future and that of nadofaragene firadonavec remain.
